Your browser doesn't support javascript.
loading
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.
Koleva-Kolarova, Rositsa; Vellekoop, Heleen; Huygens, Simone; Versteegh, Matthijs; Mölken, Maureen Rutten-van; Szilberhorn, László; Zelei, Tamás; Nagy, Balázs; Wordsworth, Sarah; Tsiachristas, Apostolos.
Afiliação
  • Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Szilberhorn L; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Zelei T; Syreon Research Institute, Budapest, Hungary.
  • Nagy B; Faculty of Social Sciences, Eötvös Loránd University, Budapest, Hungary.
  • Wordsworth S; Syreon Research Institute, Budapest, Hungary.
  • Tsiachristas A; Syreon Research Institute, Budapest, Hungary.
Per Med ; 20(4): 339-355, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37665240
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2023 Tipo de documento: Article